Cargando…
Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
The field of immuno-oncology has revolutionized cancer patient care and improved survival and quality of life for patients. Much of the focus in the field has been on exploiting the power of the adaptive immune response through therapeutic targeting of T cells. While these approaches have markedly a...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173799/ https://www.ncbi.nlm.nih.gov/pubmed/37165468 http://dx.doi.org/10.1080/19420862.2023.2208697 |